Trade Summary
3 days ago, Burnett Patrick, serving as See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 6,287 shares at $25.18 per share, for a total transaction value of $158,320.00. Following this transaction, Burnett Patrick now holds 121,150 shares of ARQT.
This sale represents a 5.00% decrease in Burnett Patrick's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 3, 2026, 1 day after the trade was made.
Arcutis Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
